Urokinase 20000IU Injection
Marketer
TTK Healthcare Ltd
Salt Composition
Urokinase (20000IU)
Overview Urokinase 20000IU Injection
Urokinase 20000IU Injection dissolves dangerous blood clots obstructing blood vessels. This medication treats patients recovering from acute myocardial infarction. Additional applications include pulmonary embolism and stroke management. Administration requires strict medical oversight; dosage and treatment length are determined individually by your physician, who will monitor your progress until stabilization. Potential side effects encompass nausea, vomiting, injection site hemorrhage, allergic responses, and hypotension. Increased bleeding risk is also possible. Your doctor will discuss the treatment's benefits and potential drawbacks before administration. Continue all prescribed medications for ongoing health conditions, even after this injection. Caution is advised for certain individuals. Therefore, disclose any bleeding disorders, kidney or liver disease, pregnancy, breastfeeding, and all other medications currently in use to your physician.
Primary Ingredients of Urokinase 20000IU Injection
The provided text is "undefined," which lacks meaning and cannot be rephrased. A rephrased version is impossible.
Uses of Urokinase 20000IU Injection
Myocardial infarction/Pulmonary thromboembolism
Major Benefits of Urokinase 20000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Urokinase 20000IU Injection:
- Allergic reaction
- Nausea
- Vomiting
- Injection site bleeding
- Decreased blood pressure
How to use Urokinase 20000IU Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Urokinase 20000IU Injection works:
Urokinase 20000IU Injection breaks down dangerous blood clots within blood vessels, re-establishing blood circulation to compromised tissues. This action averts tissue necrosis and enhances patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Urokinase 20000IU Injection may pose safety risks; seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Urokinase 20000IU Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data in humans are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of 20,000 IU Urokinase via injection appears safe for breastfeeding individuals. Available human data indicate minimal risk to the infant.
DrivingNOT RELEVANT
Urokinase 20000IU Injection is exclusively administered to inpatients; therefore, this information is inapplicable.
KidneySAFE IF PRESCRIBED
Administering 20,000 IU Urokinase injections to patients with kidney disease is likely safe. Existing evidence indicates dose modification may be unnecessary; however, professional medical advice is recommended. The use of 20,000 IU Urokinase injections is contraindicated in individuals with severe renal impairment.
LiverCAUTION
Patients with liver conditions should use Urokinase 20000IU Injection cautiously; dosage modifications may be necessary. Physician consultation is advised.
What if you forget to take Urokinase 20000IU Injection :
Should you forget a Urokinase 20000IU Injection dose, seek your physician's advice.
Facts to Know About Urokinase 20000IU Injection
| Label | Value |
|---|---|
| Chemical Category | Peptide and amino acid analogs |
| Developing Habits | No. |
| Type of Therapy | Heart |
| Actions | Early Thrombolytic Agents |
3,018 People bought this recently